NEW YORK--(BUSINESS WIRE)--Sept. 20, 2006--OMRIX Biopharmaceuticals, Inc. ("OMRIX" or the "Company") (NASDAQ: OMRI), a commercial-stage biopharmaceutical company that develops and markets biosurgical and passive immunotherapy products, announced today that Robert Taub, President and Chief Executive Officer, is scheduled to give a company presentation at the UBS Global Life Sciences Conference on Monday, September 25, 2006 at 10:00 a.m. ET at the Grand Hyatt in New York City.
